A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds

Figures & data

Figure 1 Commercially available drugs as COVID-19 Inhibitors.

Figure 2 Indole derivatives (1–4) as anti-SARS-CoV-2 agents.

Figure 3 Piperidine derivatives (5–8) as anti-SARS-CoV-2 agents.

Figure 4 Pyrazine derivatives (9 and 10) as anti-SARS-CoV-2 agents.

Figure 5 Pyridine derivatives (11 and 12) as anti-SARS-CoV-2 agents.

Figure 6 Pyrimidine derivatives (13–17) as anti-SARS-CoV-2 agents.

Figure 7 Pyrrole derivatives (18) as anti-SARS-CoV-2 agents.

Figure 8 Piperazine derivative (19) as an anti-SARS-CoV-2 agent.

Figure 9 Oxazole Derivatives (20 and 21) as anti-SARS-CoV-2 agents.

Figure 10 Quinazoline derivatives (22–25) as anti-SARS-CoV-2 agents.

Figure 11 Quinoline derivatives (26–36) as anti-SARS-CoV-2 agents.

Figure 12 Thiazole derivatives (37 and 38) as anti-SARS-CoV-2 agents.

Figure 13 Quinoxaline derivative (39) as an anti-SARS-CoV-2 agent.

Figure 14 Pyrazole derivative (40) as an anti-SARS-CoV-2 agent.

Figure 15 Benzodioxole derivatives (41 and 42) as anti-SARS-CoV-2 agents.

Figure 16 Coumarin derivatives (43 and 44) as anti-SARS-CoV-2 agents.

Figure 17 Thiadiazole derivative (45) as anti-SARS-CoV-2 agent.

Figure 18 Azafluorenere derivatives (46 and 47) as anti-SARS-CoV-2 agents.

Figure 19 Imidazole derivatives (48–54) as anti-SARS-CoV-2 agents.

Figure 20 Oxazole derivative (55) as an anti-SARS-CoV-2 agent.

Figure 21 Piperazine derivative as a (56) anti-SARS-CoV-2 agent.

Figure 22 Piperidine derivative (57) as anti-SARS-CoV-2 agent.

Figure 23 Pyrazole derivatives (58–63) as Anti-SARS-CoV-2 agents.

Figure 24 Pyridine derivatives (64–67) as anti-SARS-CoV-2 agents.

Figure 25 Pyrimidine derivatives (68–73) as anti-SARS-CoV-2 agents.

Figure 26 Quinoline derivatives (74 and 75) as anti-SARS-CoV-2 agents.

Figure 27 Quinoxaline derivative (76) as an anti-SARS-CoV-2 agent.

Figure 28 Thiadiazole derivatives (77 and 78) as an anti-SARS-CoV-2 agent.

Figure 29 Thiazole derivatives (79 and 80) as anti-SARS-CoV-2 agents.

Figure 30 Triazole derivatives (81–84) as Anti-SARS-CoV-2 agents.

Figure 31 Chloroquine derivatives (85 and 86) as anti-SARS-CoV-2 agents.

Figure 32 Chromene derivatives (87 and 88) as anti-SARS-CoV-2 agents.

Figure 33 Coumarin derivatives (89–92) as anti-SARS-CoV-2 agents.